TAB ILAC SAN A.S.

TAB ILAC SAN A.S. is a prominent Turkish pharmaceutical company dedicated to the research, development, manufacturing, and marketing of a wide range of pharmaceutical products. The company focuses on producing high-quality and effective medicines across various therapeutic areas, aiming to contribute to public health. They operate modern production facilities and adhere to stringent international quality standards and good manufacturing practices in all their operations, serving both the domestic Turkish market and international clientele.

This company is a Factory (Manufacturer).

TAB ILAC SAN A.S. produces or sells a diverse range of pharmaceutical products across numerous therapeutic areas. Their product portfolio includes medications for the gastrointestinal system such as Ranitab, Gaviscon Advance, Nexium, Motilium, and Pantpas. For the musculoskeletal system, they offer products like Apranax Forte, Voltaren, Muscoril, Dikloron, and Etol Fort. Central nervous system medications include Lyrica, Cymbalta, Xanax, Paxil, and Nöronin. They also provide treatments for systemic infections such as Augmentin, Zithromax, and Cipro. Respiratory system products include Ventolin and Singulair. Dermatological treatments like Fucidin and Zovirax are also part of their portfolio. Furthermore, they offer various vitamins and minerals including Supradyn, Bemiks, and Devit-3. Their offerings extend to products for the urogenital system, cardiovascular system, blood and blood-forming organs, diabetes, and oncology.